Soto Garcia Pâmela, Sabino Leocádio Antunes Bianca, Komatsu Daniel, de Alencar Hausen Moema, Dicko Cedric, de Rezende Duek Eliana Aparecida
Biomaterials Laboratory, Medical and Health Sciences Faculty, Pontifical Catholic University of São Paulo (PUC-SP), Sorocaba, SP 18060-030, Brazil; Pure and Applied Biochemistry, Department of Chemistry, Lund University, Lund SE-221 00, Sweden.
Biomaterials Laboratory, Medical and Health Sciences Faculty, Pontifical Catholic University of São Paulo (PUC-SP), Sorocaba, SP 18060-030, Brazil; Post-graduation Program in Materials Sciences (PPGCM), Federal University of São Carlos (UFSCar), Sorocaba 18052-780, SP, Brazil.
Int J Biol Macromol. 2025 May;307(Pt 2):141942. doi: 10.1016/j.ijbiomac.2025.141942. Epub 2025 Mar 11.
Hydrogels for biomedical applications have been widely studied once they are able to enhance the wound-healing process, as well as facilitate the controlled release and loading of drugs. In this context, Pluronic F127 (PF127) has a major role as it was shown to have exceptional versatility, once it holds unique gelation properties, as it is thermoreversible and is liquid in lower temperatures, and changes to gel in higher temperatures. Moreover, the gelation behavior of PF127 is influenced by its concentration and can be further modulated by incorporating different compounds, including drugs. In this study, the mechanical and rheological properties of Pluronic F127-based hydrogels were evaluated to be further used as a treatment for atopic dermatitis (AD). To this purpose, it was conducted Fourier transform infrared spectroscopy (FTIR), scanning electron microscopy (SEM), rheology, adhesivity, cohesion, and compression assays, allowed us to understand the effects of different concentrations of PF127 and how it behaves after incorporating compounds (chitosan grafted with hyaluronic acid (Ch/HA), and propolis), aiming to identify optimal combinations for the hydrogel formulation. To provide a reliable formulation, the study first selected the most suitable concentration of PF127, in the sequence it incorporated Ch/HA and lastly, propolis was added. The findings have provided valuable insights regarding the selection of the formulations, correlating the mechanical, rheological, and morphological data. It is expected that the formulation achieved is able to further be applied to the wounded skin, providing a low-cost and effective alternative to the treatment of AD.
用于生物医学应用的水凝胶一旦能够促进伤口愈合过程以及便于药物的控释和负载,就会得到广泛研究。在这种情况下,泊洛沙姆F127(PF127)起着重要作用,因为它具有卓越的多功能性,具有独特的凝胶化特性,它是热可逆的,在较低温度下呈液态,在较高温度下转变为凝胶。此外,PF127的凝胶化行为受其浓度影响,并且可以通过加入不同化合物(包括药物)进一步调节。在本研究中,对基于泊洛沙姆F127的水凝胶的力学和流变学性质进行了评估,以进一步用作特应性皮炎(AD)的治疗方法。为此,进行了傅里叶变换红外光谱(FTIR)、扫描电子显微镜(SEM)、流变学、粘附性、内聚力和压缩试验,使我们能够了解不同浓度的PF127的影响以及它在加入化合物(接枝透明质酸的壳聚糖(Ch/HA)和蜂胶)后的行为,旨在确定水凝胶配方的最佳组合。为了提供可靠的配方,该研究首先选择了最合适的PF127浓度,接着加入Ch/HA,最后加入蜂胶。这些发现为配方的选择提供了有价值的见解,将力学、流变学和形态学数据关联起来。预计所得到的配方能够进一步应用于受伤皮肤,为AD的治疗提供一种低成本且有效的替代方法。